leisure time -WSS

leisure time

author：comprehensive 2025-10-04 03:59:16 - browse：1

How do cancer drugs work? What makes biotech stocks go up? And why are venture capitalists so optimistic?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Andrew Joseph joins us to explain the decades-old cancer-treating technology that had its star turn at this week’s big oncology conference in Europe. We also discuss the latest news in the life sciences, including the future of Alzheimer’s disease treatment, a multibillion-dollar deal, and the return of the biotech mega-round.

For more on what we cover, here’s STAT’s coverage of the European Society for Medical Oncology meeting; here’s more on Roivant Sciences; here’s the latest on biotech venture capital; here’s more on the latest Alzheimer’s data; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Why age limits for politicians are a terrible idea

WSS

Physician executives need more than on

Analysis of telehealth claims data suggest service duplication

Stroke deaths set to near 10 million globally by 2050

A virus, fished out of a lake, may have saved a man’s life

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

Phenylephrine and the overlooked value of the placebo effect

hotspot

leisure time

leisure time

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

AI can decode, harness the power of the humane immune system

Supreme Court strikes down use of affirmative action

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

Jerome Adams on the need for new antivirals for Covid

Was Amgen transparent enough on FDA's concern on cancer drug?

In Memoriam: Notable people who died in 2023

Liquid biopsy for lung cancer is launched by Delfi

Psychedelics group wrestles with new pharma identity

Study: Hearing aids may slow cognitive decline in those at risk

explore

FDA seeking to stop procedures at two unregulated stem cell clinics

House passes resolution saying Israel isn't a 'racist or apartheid state'

Senate panel eyes new effort on drug shortages

BridgeBio heart drug succeeds in pivotal study

Biden administration sends mixed signals on US soldier who crossed into North Korea

More hospitals are billing patients as online messages surge

Wikipedia

knowledge

focus

hotspot